NBY

AMEXStock

NovaBay Pharmaceuticals, Inc.

$1.18-0.09 (-7.09%)

52-Week Range

$1.24

$95.80

Key Stats

Market Cap

30.8M

P/E Ratio

1.36

Dividend Yield

68.97%

Beta

0.20

Volume

159.4K

Avg Volume

525.0K

Performance

-56.28%

-90.63%

-90.73%

YTD

-95.67%

-59.69%

-99.53%

-99.98%

Price Chart

ETF Exposure

NBY is held by 4 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VXF	Vanguard Extended Market ETF	0.00%	1,360,782	$2.5M	$84.10B	0.05%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	55,800	$71K	$80.22B	0.03%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	55,800	$6K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	55,800	$2K	$3.91B	0.07%

About NBY ETF Exposure

NovaBay Pharmaceuticals, Inc. (NBY) is held by 4 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 30.8M, NBY is a widely held institutional stock. The stock currently trades at $1.18 with a dividend yield of 68.97%. Investors can gain exposure to NBY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NBY, sorted by portfolio weight.